Familial Hypercholesterolemia can have devastating consequences – stealing people away from the people who love them. Today, we are honored to share this story from community member April Irene Donelson. April lost her fiancée to a sudden heart attack just months before they were to be married. … Read More
Monthly Archives: February 2019
The FH Foundation welcomes Sanofi and Regeneron’s announcement today to lower the list price of its LDL cholesterol lowering treatment, the PCSK9 inhibitor Praluent, to $5,850 annually. This brings the list price of Praluent in line with Amgen’s PCSK9 inhibitor, Repatha, which was lowered … Read More
The FH Foundation went to Capitol Hill on January 28-29 to raise awareness of Familial Hypercholesterolemia among our nation’s elected officials, and advocate for Federal funding for FH research.
Our 2019 class of 25 new volunteer FH Advocates for Awareness held 36 meetings with Congressional Offices … Read More
(BPT) One in four deaths in the U.S. is caused by heart disease. More than 610,000 people die of heart disease in the U.S. every year, making it the leading cause of death for both men and women, according to the Centers for Disease Control and Prevention. It’s no surprise heart health … Read More